What Virtual screening is designed to address
Virtual screening is not a one-score software run. It is a reviewable analysis path organised around “How can screening cost be controlled while retaining diversity and interpretability?”, beginning with input quality, comparators and intended use of evidence before selecting an appropriate methodological level.
The work centres on Library standardisation and deduplication, Pharmacophore, similarity and structure-based screening, Consensus ranking and cluster-based selection and links Target or reference ligand, Vendor or proprietary library, Screening constraints directly to Screening funnel record, Structurally diverse candidate set, Procurement and validation suggestions. Reporting separates supporting evidence, conflicting signals, parameter dependence and conditions for follow-up validation.
How can screening cost be controlled while retaining diversity and interpretability?
Suitable research settings
- Projects that need to answer “How can screening cost be controlled while retaining diversity and interpretability?”
- Studies requiring consistent comparison and quality control across Library standardisation and deduplication and Pharmacophore, similarity and structure-based screening
- Teams that need Screening funnel record, Structurally diverse candidate set, Procurement and validation suggestions with complete reproduction records
Analyses included in the service
Library standardisation and deduplication
Apply Library standardisation and deduplication to target or reference ligand and produce screening funnel record. First confirm that target or reference ligand can support the downstream analysis.
Pharmacophore, similarity and structure-based screening
Apply Pharmacophore, similarity and structure-based screening to vendor or proprietary library and produce structurally diverse candidate set. Use consistent systems, conditions and naming across adjacent steps so comparisons remain reviewable.
Consensus ranking and cluster-based selection
Apply Consensus ranking and cluster-based selection to screening constraints and produce procurement and validation suggestions. Use consistent systems, conditions and naming across adjacent steps so comparisons remain reviewable.
Select the methodological level for the question
| Method | Best suited to | Watch for |
|---|---|---|
| Library standardisation and deduplication | Establishing the input baseline and initial search space for Virtual screening | Errors in Virtual screening input state, structure or data definition propagate through later steps |
| Pharmacophore, similarity and structure-based screening | Comparing candidate states, features or mechanisms in Virtual screening to form priorities | Virtual screening comparisons require consistent conditions; raw scores are not experimental measurements |
| Consensus ranking and cluster-based selection | Reviewing key Virtual screening results, interpreting differences and recording uncertainty | Ranking depends on structure quality, sampling and scoring; hits require experimental confirmation. |
From question definition to reproducible delivery
Frame the research question
Use “How can screening cost be controlled while retaining diversity and interpretability?” to define comparators, decision use, experimental context and the strength of evidence the computation can support.
Review and curate inputs
Review Target or reference ligand, Vendor or proprietary library, Screening constraints; resolve structure, naming, unit, batch or microstate issues and record any remaining assumptions.
Design methods and controls
Combine Library standardisation and deduplication, Pharmacophore, similarity and structure-based screening, Consensus ranking and cluster-based selection with controls, replicates, sensitivity checks or independent evidence, defining decision criteria before computation.
Compute with quality control
Run Virtual screening, including Library standardisation and deduplication, in a reproducible environment; retain inputs, versions, parameters, logs and intermediate outputs, and flag convergence, sampling, data-quality and applicability issues.
Interpret and deliver
Organise Screening funnel record, Structurally diverse candidate set, Procurement and validation suggestions while separating direct observations, model inference and working hypotheses, then prioritise experiments or follow-up computation.
What is needed and what is delivered
Inputs
- Target or reference ligand
- Vendor or proprietary library
- Screening constraints
Optional supporting inputs
- Known positive, negative or reference systems for basic expectation checks in Virtual screening
- Replicate experiments, external databases or literature evidence relevant to Virtual screening
- Timing, compute, software-compatibility or delivery-format constraints for Virtual screening
Deliverables
- Screening funnel record
- Structurally diverse candidate set
- Procurement and validation suggestions
Quality control and interpretation limits
How results are reviewed
- Virtual screening: Standardise chemical structures, target states and assay context
- Virtual screening: Review against known actives, decoys or simple baselines
- Virtual screening: Record applicability domain, score agreement and uncertainty
- Virtual screening: Check diversity, synthesizability and experimental testability
Boundaries that remain
- Ranking depends on structure quality, sampling and scoring; hits require experimental confirmation.
- Virtual screening results apply only to the recorded inputs, parameters, models and sampling scope. Changes to input state, comparison conditions or project objectives may require new computation.
Common ways projects begin
From one system to comparable candidates
When target or reference ligand are available but decision criteria are inconsistent, establish baselines and controls, then use Library standardisation and deduplication, Pharmacophore, similarity and structure-based screening, Consensus ranking and cluster-based selection to build candidate tiers and deliver screening funnel record with a difference analysis.
Independent review of existing results
When results relevant to Virtual screening conflict, revisit target or reference ligand and analytical assumptions around Library standardisation and deduplication, then add replicates, sensitivity checks or alternative models to distinguish signal from method conditions.
Questions before a project begins
What is required before Virtual screening begins?
The minimum inputs are Target or reference ligand, Vendor or proprietary library, Screening constraints. If information is incomplete, an input audit identifies which gaps change method selection and which can be handled as explicit assumptions.
Can the result directly prove “How can screening cost be controlled while retaining diversity and interpretability?”?
No single model output should be treated as experimental fact. Ranking depends on structure quality, sampling and scoring; hits require experimental confirmation. Quality controls determine whether results support a priority or mechanism hypothesis; key conclusions still require appropriate experiments or independent data.
Which reusable files are delivered?
Typical delivery includes Screening funnel record, Structurally diverse candidate set, Procurement and validation suggestions, together with input-curation records, key parameters, software and database versions, quality-control results, editable figures and limitations. Exact raw formats are confirmed in the project plan.